Calcichew marketing moves from Shire to Takeda

Takeda Nycomed AS announced today that they have signed a short term extension to the Supply and Distribution agreement with Shire Pharmaceuticals Ireland Limited relating to the ownership and promotion of the Calcichew® portfolio in the UK and Ireland. Under the terms of the extension agreement, Shire shall continue as the Product Marketing Authorisation holder in the UK and Ireland and will be responsible for sales and distribution of the Calcichew® portfolio until 31st December 2013. Shire and Takeda will collaborate on the transition of activities during 2013, with Takeda taking responsibility for the promotion and marketing of the Calcichew® portfolio from